法国COBRA成人哮喘队列的临床与生物学特征
COBRA是一项涉及12家法国学术机构的纵向队列,2007至2015年纳入1080例哮喘患者,其中401例轻中度、613例重度。横断面分析显示重度哮喘患者症状、急性加重、住院和急诊就诊更多,血嗜酸性粒细胞更高且合并症更多;纵向分析显示嗜酸性粒细胞数量及其随时间增加与后续急性加重次数和Juniper评分相关。
要点
- 重度哮喘患者症状负担、急性加重、住院及急诊就诊均高于轻中度患者。
- 超过60%重度哮喘患者入组时治疗未控制,其中152例正接受奥马珠单抗治疗。
- 血嗜酸性粒细胞>300/mm3者哮喘病程更短、肺功能更低、重度急性加重更多且控制更差。
核心结论
- 重度哮喘患者临床负担和合并症更多,血嗜酸性粒细胞增高与更差的控制和更多急性加重相关。
研究设计与样本
- COBRA为涉及12家法国学术机构的纵向队列,2007至2015年纳入1080例成人哮喘患者,入组及每6个月收集DNA、血清和临床数据。
主要发现
- 1080例中401例为轻中度哮喘,613例为重度哮喘。
- 重度哮喘患者过去12个月症状、急性加重、住院和急诊就诊更多,血嗜酸性粒细胞更高且合并症更多。
- 超过60%重度哮喘患者入组时治疗未控制,其中152例正接受奥马珠单抗治疗。
- 血嗜酸性粒细胞>300/mm3者较低于该水平者哮喘病程更短、肺功能更低、重度急性加重率更高且哮喘控制更差。
- 427例至少三次血细胞分类计数的纵向分析显示,嗜酸性粒细胞数量及其随时间增加与至下次访视前的急性加重次数和Juniper评分相关。
临床怎么用
- 对重度哮喘患者应关注症状、急性加重、住院和急诊就诊等负担及合并症评估。
- 血嗜酸性粒细胞>300/mm3提示更短病程、更低肺功能和更高重度急性加重风险及更差控制。
- 动态监测血嗜酸性粒细胞数量及其变化有助于评估后续急性加重风险和控制水平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The COhort of BRonchial obstruction and Asthma (COBRA) is a longitudinal cohort that involves 12 French academic institutions. DNA, serum samples and clinical data are collected at entry and every 6 months thereafter.Of 1080 patients with asthma recruited between 2007 and 2015, 401 had mild/moderate and 613 had severe asthma. In cross-sectional analyses, compared with patients with milder disease, patients with severe asthma had more symptoms, exacerbations, hospitalisations and visits to the emergency department during the preceding 12 months, higher numbers of blood eosinophils, and more comorbidities. More than 60% of patients with severe asthma were therapy-uncontrolled at entry, and 152 of them were being treated with omalizumab. In addition, patients with asthma who had the highest eosinophilia levels (>300/mm3) had shorter asthma duration, lower lung function, and higher rates of severe exacerbations and unacceptable asthma control than patients with lower eosinophil counts.Longitudinal analyses performed in 427 patients with asthma with at least three differential blood cell counts demonstrated that both eosinophil numbers and eosinophil increase over time were associated with the number of exacerbations occurring until the next visit and with Juniper score.Studies with the COBRA cohort will help to improve knowledge concerning the risk and biological factors associated with asthma severity and to better understand their influence on the disease trajectory.
引用
- Pretolani M, Soussan D, Poirier I, et al. Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma. Eur Respir J. 2017. PMID: 28838976. doi:10.1183/13993003.00019-2017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。